Siofoki Korhaz-Rendelointezet
- Address
- Semmelweis Utca 1, 8600 Siófok, Hungary
Siofoki Korhaz-Rendelointezet
Siofoki Korhaz-Rendelointezet is a clinical research institution specializing in diverse therapeutic areas, with particular expertise in chronic disease management and acute critical care conditions. The center demonstrates a strong commitment to advancing treatments across multiple organ systems, from renal and respiratory disorders to chronic inflammatory conditions.
- Chronic kidney disease and hypertension management, including novel combination therapies targeting CKD progression
- Acute respiratory distress syndrome (ARDS) caused by pneumonia and infectious diseases
- Chronic rhinosinusitis with nasal polyps (CRSwNP) and associated respiratory conditions including asthma
The research center actively participates in international Phase III clinical trials evaluating innovative therapeutic approaches. Their portfolio includes investigations of nephroprotective interventions using advanced drug combinations, critical care therapies utilizing recombinant biologic agents for severe respiratory complications, and targeted eosinophilic inflammatory pathway treatments for complex upper airway diseases. This multidisciplinary approach positions the institution at the forefront of both chronic disease prevention and acute illness intervention research.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Bioaegis Therapeutics Inc.1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 332 other sites in Hungary
Therapeutic Area Benchmark — Hungary
Select a therapeutic area to compare against other sites in Hungary.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Hungary
Market Share
Country: Hungary
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Siofoki Korhaz-Rendelointezet
lock Showing 1 of 4 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety of Benralizumab in Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma: A Randomized, Double-Blind, Placebo-Controlled Study | AstraZeneca AB | Phase III | Not Recruiting | Oct 2021 | Dec 2024 |
IMP list
lock Showing 1 of 10 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Baxdrostat | 1 | Unknown | 2024-06-05 | 2024-06-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.